The relative importance of sarcopenia and its individual components as
independent predictors of mortality in the dialysis population have not been
determined. We estimated whole-body muscle mass using pre-dialysis bioimpedance
spectroscopy measurements in 645 ACTIVE/ADIPOSE enrolled prevalent hemodialysis
patients from San Francisco and Atlanta. Low muscle mass was defined as two
standard deviations below sex-specific means for young adults from NHANES and
indexed to height2, body weight, body surface area, or body mass
index. We evaluated the association of sarcopenia (low muscle mass) by four
indexing methods, weak handgrip strength, and slow gait speed with mortality.
Seventy-eight deaths were observed during a mean follow-up of 1.9 years.
Sarcopenia was not significantly associated with mortality after adjusting for
covariates. No muscle mass criteria were associated with death, regardless of
indexing metrics. In contrast, having weak grip strength or slow walking speed
was associated with mortality in the adjusted model. Only gait slowness
significantly improved the predictive accuracy for death with an increase in
C-statistic from 0.63 to 0.68. However, both gait slowness and hand grip
weakness significantly improved the net reclassification index compared to
models without performance measures (50.5% for slowness and
33.7% for weakness), whereas models with muscle size did not. Neither
sarcopenia nor low muscle mass by itself was a better predictor of mortality
than functional limitation alone in patients receiving hemodialysis. Thus,
physical performance measures, including slow gait speed and weak hand grip
strength, were associated with mortality even after adjustment for muscle size
and other confounders.